Access to anti-retroviral drugs, male in Guyana
Guyana: Access to anti-retroviral drugs, male was 66.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Guyana, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Guyana recorded 66.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 6.5% on the previous year and up 37.5% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Guyana peaked at 66.0% in 2024 and was at its lowest, 0.0%, in 2000.
Guyana ranks 80th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Guyana, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 3.0% | — |
| 2004 | 10.0% | +233.3% |
| 2005 | 22.0% | +120.0% |
| 2006 | 27.0% | +22.7% |
| 2007 | 31.0% | +14.8% |
| 2008 | 34.0% | +9.7% |
| 2009 | 37.0% | +8.8% |
| 2010 | 38.0% | +2.7% |
| 2011 | 41.0% | +7.9% |
| 2012 | 44.0% | +7.3% |
| 2013 | 46.0% | +4.5% |
| 2014 | 48.0% | +4.3% |
| 2015 | 50.0% | +4.2% |
| 2016 | 53.0% | +6.0% |
| 2017 | 57.0% | +7.5% |
| 2018 | 56.0% | -1.8% |
| 2019 | 59.0% | +5.4% |
| 2020 | 57.0% | -3.4% |
| 2021 | 59.0% | +3.5% |
| 2022 | 60.0% | +1.7% |
| 2023 | 62.0% | +3.3% |
| 2024 | 66.0% | +6.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 16.4% | 0.0% | 37.0% | 10 |
| 2010s | 49.2% | 38.0% | 59.0% | 10 |
| 2020s | 60.8% | 57.0% | 66.0% | 5 |
Countries ranked near Guyana
More gender data for Guyana
- Child population (UN estimates and projections) 236.01 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.7051 % change on previous year (2030)
- Population 625.02 (2030)
- Working-age population (UN estimates and projections) 625.02 (2030)
- Population (UN estimates and projections), annual growth rate 1.08 % change on previous year (2030)
- Age population, age 00, female, interpolated 7,888 (2025)
- Age population, age 00, male, interpolated 8,132 (2025)
- Age population, age 01, female, interpolated 7,912 (2025)
- Age population, age 01, male, interpolated 8,158 (2025)
- Age population, age 02, female, interpolated 7,973 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Guyana?
- Access to anti-retroviral drugs, male in Guyana was 66.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Guyana?
- The highest recorded value was 66.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Guyana?
- The lowest recorded value was 0.0% in 2000.
- How does Guyana rank for access to anti-retroviral drugs, male?
- Guyana ranks 80th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Guyana?
- Over the last ten years it is up 37.5%. The long-run trend across the full record is volatile.
- Where does this Guyana data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.